The city of Huntington Beach, California, currently has 1 active clinical trials seeking participants for Pulmonary Fibrosis research studies.
To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF
Recruiting
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, study to evaluate the efficacy, safety, and tolerability of 200 mg twice daily (BID) of BBT-877 in patients with IPF, with or without AF approved background therapies (pirfenidone or nintedanib).
Gender:
All
Ages:
40 years and above
Trial Updated:
05/28/2024
Locations: SoCal Clinical Research, Huntington Beach, California
Conditions: Idiopathic Pulmonary Fibrosis